Kailo Medical Integrates With Medo AI to Standardize Thyroid Ultrasound Practices

By AIT News Desk On May 31, 2021

Kailo Medical, a healthcare technology company with products that streamline structured reporting in the hospital setting, announces its integration with Medo, an Artificial Intelligence company dual-headquartered in Singapore and Edmonton. The integration will see Medo Thyroid integrated into Kailo’s SonoReview product to make nodule classification quicker, simpler and more accurate, ultimately leading to better outcomes for patients.

“Kailo’s SonoReview is a powerful tool that streamlines structured reporting for radiologists worldwide,” said Jessica Wilson, VP North America at Kailo Medical. “The integration of MEDO’s AI technology has the potential to double patient throughput and enable technologists and radiologists to more accurately assess, categorize and diagnose radiology findings, doing away with unnecessary follow up testing that can bring patients anxiety and stress.”

Evolution Equity Partners Invests In Series B Round of Augment Inc. Empowering Software Development Teams With AI

Nov 4, 2024

Advex AI Raises $3.5Million Seed Round, Launches Revolutionary GenAI Synthetic Data Platform for AI Vision in Manufacturing

Nov 4, 2024

View Systems Announces General Availability of AI Data Management and Insights Platform

Nov 4, 2024

Prev Next 1 of 40,347

The collaboration with Medo leverages AI and machine learning to analyze, assess and categorize thyroid ultrasound imaging using TI-RADS classification, all powered by the structured reporting delivered by Kailo’s SonoReview. The paired technologies enable technologists and radiologists to make more informed and confident decisions, standardise diagnoses and over time, reduce margin of error to deliver better health outcomes for all.

“MEDO.ai automates the mundane, difficult and subjective elements of exams – but this value is only truly realized when it’s incorporated directly into the workflow of users, as demonstrated by this integration with SonoReview,” says David Quail, Co-Founder at MEDO.ai. “The integration of the two solutions allows users to benefit from Kailo Medical’s efficiency gains as well as MEDO’s AI assistance, all seamlessly integrated within their workflow. The union of these two groundbreaking technologies is set to deliver a better user and patient experience.”